Tarik Skubal’s return to the mound is gaining renewed attention—not just for his remarkable performance, but for the innovative procedure that got him there.
The Detroit Tigers starting pitcher and two-time Cy Young Award winner underwent an elbow procedure on May 6 to remove a loose body of calcified cartilage, an issue that had caused pain and limited his ability to pitch. Following a stint on the Injured List, Skubal returned to play on June 13, less than six weeks after surgery.
Orthopedic surgeon Neal ElAttrache, MD (Los Angeles, CA), performed the procedure using the Arthrex NanoNeedle™ scope 2.0 to remove the loose body through Nano arthroscopy while limiting disruption to surrounding tissue.
In earlier coverage, Dr. ElAttrache noted that the ultra-minimally invasive approach allowed him to avoid going through the triceps tendon—a step that can often contribute to added discomfort and a longer recovery with traditional techniques.
That detail has become a focal point in follow-up reporting, as sports journalists and media outlets examine how smaller-incision approaches may influence early recovery, particularly for elite athletes, where time away from play is closely scrutinized.
Since the initial news broke, Skubal’s case has been widely covered by national media outlets including ESPN, The Athletic, Fox Sports and USA Today. Early reporting focused on the injury and procedure itself, while more recent coverage has shifted to the pace of his recovery and what it may signal about evolving treatment approaches in professional sports.
Associated Press writer Jay Cohen wrote, “Several top pro athletes and their surgeons say a modern version of an old tool is shaving weeks off recovery time for certain injuries. And some top doctors think this is only the beginning.”
[ Read the story here: Tarik Skubal, the Cleveland Browns and other athletes credit a tiny new scope for faster recoveries ]
Recent coverage in The Wall Street Journal and Sports Grid has also explored the broader implications for baseball, with headlines such as “It’s Called the NanoNeedle—and It’s Fixing Baseball’s Broken Pitchers” and “Tarik Skubal’s Impressive Return: Medical Advances in Baseball.”
Skubal’s return is part of a growing body of coverage around the use of the NanoNeedle in professional sports. Similar cases, including pitcher Blake Snell, who was also operated on by Dr. ElAttrache, have drawn attention to its use among elite athletes. NHL MVP and Olympic gold medalist Connor Hellebuyck's successful return from meniscal surgery with the NanoNeedle scope 2.0 further reflects how this next-generation technology could help more athletes return to competition with less pain and potentially faster recovery.